Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.9 USD | -1.59% | +12.37% | -31.59% |
May. 08 | Wedbush Raises Viridian Therapeutics Price Target to $42 From $40, Maintains Outperform Rating | MT |
May. 08 | Earnings Flash (VRDN) VIRIDIAN THERAPEUTICS Reports Q1 Revenue $72,000 | MT |
- Stock Market
- Equities
- VRDN Stock
- News Viridian Therapeutics, Inc.